Ennature Bio Pharma Lists on NSE and BSE
The company made its market debut on Wednesday, November 4, 2026. For FY26, it reported net revenue of ₹246 crore and EBITDA of ₹29 crore.
Ennature Bio Pharma Limited made its stock market debut on the National Stock Exchange and BSE on Wednesday, November 4, 2026. The company, a demerged division of India Glycols Limited.The company reported net revenue of ₹246 crore, EBITDA of ₹29 crore, and a gross margin of 40.1 per cent for FY26…